Charles River Laboratories International, Inc.
CRL
$178.12
$2.201.25%
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 22.20M | 423.78M | 441.51M | 444.45M | 474.62M |
| Total Depreciation and Amortization | 352.34M | 340.15M | 330.82M | 322.41M | 314.12M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 390.36M | -18.23M | -3.79M | -3.93M | -2.47M |
| Change in Net Operating Assets | -30.33M | 50.46M | -18.73M | -58.53M | -102.38M |
| Cash from Operations | 734.58M | 796.16M | 749.82M | 704.40M | 683.90M |
| Capital Expenditure | -232.97M | -235.67M | -262.90M | -290.80M | -318.53M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -5.48M | -150.10M | -150.10M | -144.62M | -194.79M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.64M | -21.58M | -52.59M | -44.91M | -49.84M |
| Cash from Investing | -245.09M | -407.35M | -465.59M | -480.33M | -563.16M |
| Total Debt Issued | 1.08B | 1.42B | 1.24B | 884.74M | 776.35M |
| Total Debt Repaid | -1.49B | -1.64B | -1.52B | -986.83M | -851.68M |
| Issuance of Common Stock | 23.88M | 29.05M | 32.21M | 35.31M | 25.60M |
| Repurchase of Common Stock | -119.18M | -119.19M | -18.44M | -14.49M | -24.16M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -43.44M | -43.68M | -34.36M | -11.14M | -11.64M |
| Cash from Financing | -550.93M | -351.48M | -306.81M | -92.42M | -85.52M |
| Foreign Exchange rate Adjustments | -17.47M | 8.70M | -5.19M | -2.01M | 8.04M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -78.91M | 46.02M | -27.77M | 129.64M | 43.27M |
